384 related articles for article (PubMed ID: 30096408)
1. Sympathoadrenergic suppression improves heart function by upregulating the ratio of sRAGE/RAGE in hypertension with metabolic syndrome.
Selejan SR; Linz D; Tatu AM; Hohl M; Speer T; Ewen S; Mahfoud F; Kindermann I; Zamyatkin O; Kazakov A; Laufs U; Böhm M
J Mol Cell Cardiol; 2018 Sep; 122():34-46. PubMed ID: 30096408
[TBL] [Abstract][Full Text] [Related]
2. Renal denervation reduces atrial remodeling in hypertensive rats with metabolic syndrome.
Selejan SR; Linz D; Mauz M; Hohl M; Huynh AKD; Speer T; Wintrich J; Kazakov A; Werner C; Mahfoud F; Böhm M
Basic Res Cardiol; 2022 Jul; 117(1):36. PubMed ID: 35834066
[TBL] [Abstract][Full Text] [Related]
3. Progression of kidney injury and cardiac remodeling in obese spontaneously hypertensive rats: the role of renal sympathetic innervation.
Linz D; Hohl M; Schütze J; Mahfoud F; Speer T; Linz B; Hübschle T; Juretschke HP; Dechend R; Geisel J; Rütten H; Böhm M
Am J Hypertens; 2015 Feb; 28(2):256-65. PubMed ID: 25023205
[TBL] [Abstract][Full Text] [Related]
4. Anti-hyperglycemic activity of moxonidine: metabolic and molecular effects in obese spontaneously hypertensive rats.
Friedman JE; Ishizuka T; Liu S; Farrell CJ; Koletsky RJ; Bedol D; Ernsberger P
Blood Press Suppl; 1998; 3():32-9. PubMed ID: 10321453
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of antihyperglycemic effects of moxonidine in the obese spontaneously hypertensive Koletsky rat (SHROB).
Ernsberger P; Ishizuka T; Liu S; Farrell CJ; Bedol D; Koletsky RJ; Friedman JE
J Pharmacol Exp Ther; 1999 Jan; 288(1):139-47. PubMed ID: 9862764
[TBL] [Abstract][Full Text] [Related]
6. Soluble Receptor for Advanced Glycation End Products: A Protective Molecule against Intramyocardial Lipid Accumulation in Obese Zucker Rats?
Dozio E; Vianello E; Bandera F; Longhi E; Brizzola S; Nebuloni M; Corsi Romanelli MM
Mediators Inflamm; 2019; 2019():2712376. PubMed ID: 30944546
[TBL] [Abstract][Full Text] [Related]
7. Soluble Receptor for Advanced Glycation End-products regulates age-associated Cardiac Fibrosis.
Scavello F; Zeni F; Milano G; Macrì F; Castiglione S; Zuccolo E; Scopece A; Pezone G; Tedesco CC; Nigro P; Degani G; Gambini E; Veglia F; Popolo L; Pompilio G; Colombo GI; Bianchi ME; Raucci A
Int J Biol Sci; 2021; 17(10):2399-2416. PubMed ID: 34326683
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
Basta G; Del Turco S; Navarra T; Lee WM;
Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice.
Gopal P; Gosker HR; Theije CC; Eurlings IM; Sell DR; Monnier VM; Reynaert NL
Biochim Biophys Acta; 2015 May; 1852(5):992-1000. PubMed ID: 25703138
[TBL] [Abstract][Full Text] [Related]
10. Sympathetic nervous system in salt-sensitive and obese hypertension: amelioration of multiple abnormalities by a central sympatholytic agent.
Ernsberger P; Koletsky RJ; Collins LA; Bedol D
Cardiovasc Drugs Ther; 1996 Jun; 10 Suppl 1():275-82. PubMed ID: 8827950
[TBL] [Abstract][Full Text] [Related]
11. ADAM10 modulates calcitriol-regulated RAGE in cardiomyocytes.
Lee TW; Kao YH; Lee TI; Chen YJ
Eur J Clin Invest; 2017 Sep; 47(9):675-683. PubMed ID: 28722189
[TBL] [Abstract][Full Text] [Related]
12. Soluble receptor for advanced glycation end products mitigates vascular dysfunction in spontaneously hypertensive rats.
Liu Y; Yu M; Zhang L; Cao Q; Song Y; Liu Y; Gong J
Mol Cell Biochem; 2016 Aug; 419(1-2):165-76. PubMed ID: 27426491
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency Renal Denervation Protects the Ischemic Heart via Inhibition of GRK2 and Increased Nitric Oxide Signaling.
Polhemus DJ; Gao J; Scarborough AL; Trivedi R; McDonough KH; Goodchild TT; Smart F; Kapusta DR; Lefer DJ
Circ Res; 2016 Jul; 119(3):470-80. PubMed ID: 27296507
[TBL] [Abstract][Full Text] [Related]
14. JNK and ATF4 as two important platforms for tumor necrosis factor-α-stimulated shedding of receptor for advanced glycation end products.
Miyoshi A; Koyama S; Sasagawa-Monden M; Kadoya M; Konishi K; Shoji T; Inaba M; Yamamoto Y; Koyama H
FASEB J; 2019 Mar; 33(3):3575-3589. PubMed ID: 30452882
[TBL] [Abstract][Full Text] [Related]
15. Suppressed MMP-9 Activity in Myocardial Infarction-Related Cardiogenic Shock Implies Diminished Rage Degradation.
Selejan SR; Hewera L; Hohl M; Kazakov A; Ewen S; Kindermann I; Böhm M; Link A
Shock; 2017 Jul; 48(1):18-28. PubMed ID: 28608784
[TBL] [Abstract][Full Text] [Related]
16. Critical role of RAGE and HMGB1 in inflammatory heart disease.
Bangert A; Andrassy M; Müller AM; Bockstahler M; Fischer A; Volz CH; Leib C; Göser S; Korkmaz-Icöz S; Zittrich S; Jungmann A; Lasitschka F; Pfitzer G; Müller OJ; Katus HA; Kaya Z
Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E155-64. PubMed ID: 26715748
[TBL] [Abstract][Full Text] [Related]
17. Perivascular radiofrequency renal denervation lowers blood pressure and ameliorates cardiorenal fibrosis in spontaneously hypertensive rats.
Wei S; Li D; Zhang Y; Su L; Zhang Y; Wang Q; Yang D; Li D; Yang Y; Ma S
PLoS One; 2017; 12(4):e0176888. PubMed ID: 28453557
[TBL] [Abstract][Full Text] [Related]
18. sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells.
Zhang F; Su X; Huang G; Xin XF; Cao EH; Shi Y; Song Y
Sci Rep; 2017 Oct; 7(1):14268. PubMed ID: 29079726
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the receptor for advanced glycation end products in liver transplantation.
Navarra T; De Simone P; Del Turco S; Filipponi F; Basta G
Ann Hepatol; 2015; 14(2):190-7. PubMed ID: 25671828
[TBL] [Abstract][Full Text] [Related]
20. The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway.
Tian Y; Charles EJ; Yan Z; Wu D; French BA; Kron IL; Yang Z
J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2256-2269.e3. PubMed ID: 30401529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
